Norway· NO-ID_7E0720FF-39A6-402E-AEE6-B715B027A149

Ocaliva

A obeticholic acid product containing obeticholic acid, registered in Norway by Advanz Pharma Limited. The same ATC class is registered in 7 of our 19 countries.

ATC A05AA04

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedOcalivaATCA05AA04REGISTER NO.NO-ID_7E0720FF-39A6-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Obeticholic acid is registered in 7 of 19 countries.

Countries holding a registration under ATC A05AA04 (obeticholic acid), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 3 of them publish a price we can compare per daily dose

Obeticholic acid · ATC A05AA04

7 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Ireland
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Obeticholic Acid
Manufacturer
Advanz Pharma Limited
Country
Norway (NO)
ATC code
A05AA04
ATC class
Obeticholic acid
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_7E0720FF-39A6-402E-AEE6-B715B027A149
  • no_varenummer
    290818
    30
  • gtin
    5021691003915

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

49 interactions on record for obeticholic acid.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Obeticholic acid · interactions on record

49 records

  • 2 severe
  • 44 moderate
  • 3 minor

Most severe, free to view

  • GrazoprevirJ05AP11severe
  • TizanidineM03BX02severe
  • AlosetronA03AE01moderate
  • DicoumarolB01AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Obeticholic acid in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All obeticholic acid products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • United Kingdom (Northern Ireland) · Ocaliva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5947515c-a373-4acd-8c1c-5f96edb9c52d
GET /v1/drugs/5947515c-a373-4acd-8c1c-5f96edb9c52d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Obetikolsyre",
  "merkevare_id": "ID_7E0720FF-39A6-402E-AEE6-B715B027A149",
  "name_form_strength": "Ocaliva tab 10 mg",
  "prescription_group": "C"
}

See everything about obeticholic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.